| Literature DB >> 26300756 |
Christopher L Striemer1, David Cantelmi2, Michael D Cusimano3, James A Danckert4, Tom A Schweizer5.
Abstract
Traditionally the cerebellum has been known for its important role in coordinating motor output. Over the past 15 years numerous studies have indicated that the cerebellum plays a role in a variety of cognitive functions including working memory, language, perceptual functions, and emotion. In addition, recent work suggests that regions of the cerebellum involved in eye movements also play a role in controlling covert visual attention. Here we investigated whether regions of the cerebellum that are not strictly tied to the control of eye movements might also contribute to covert attention. To address this question we examined the effects of circumscribed cerebellar lesions on reflexive covert attention in a group of patients (n = 11) without any gross motor or oculomotor deficits, and compared their performance to a group of age-matched controls (n = 11). Results indicated that the traditional RT advantage for validly cued targets was significantly smaller at the shortest (50 ms) SOA for cerebellar patients compared to controls. Critically, a lesion overlap analysis indicated that this deficit in the rapid deployment of attention was linked to damage in Crus I and Crus II of the lateral cerebellum. Importantly, both cerebellar regions have connections to non-motor regions of the prefrontal and posterior parietal cortices-regions important for controlling visuospatial attention. Together, these data provide converging evidence that both lateral and midline regions of the cerebellum play an important role in the control of reflexive covert visual attention.Entities:
Keywords: Crus I; Crus II; attention; cerebellum; covert attention; eye movements; lateral cerebellum
Year: 2015 PMID: 26300756 PMCID: PMC4523795 DOI: 10.3389/fnhum.2015.00428
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Patient demographics and clinical data.
| 1 | F | 55 | 12 | Tumor | 1095 | R | VIIIA, VIIB, CrII, CrI |
| 2 | F | 43 | 12 | Tumor | 1144 | R | VIIIA, VIIB, CrII, CrI |
| 3 | M | 42 | 21 | Vascular | 744 | L | VIIA, VIIB, VIIIA, CrI, CrII |
| 4 | M | 60 | 8 | Tumor | 352 | L | VIIB, CrI |
| 5 | M | 51 | 12 | Tumor | 1151 | L | CrI, CrII, VI |
| 6 | F | 70 | 12 | Tumor | 3864 | L | CrI, CrII, VIIB, III, IV, V, VI |
| 7 | M | 44 | 12 | Tumor | 1532 | R | VIIIA, VIIIB |
| 8 | F | 26 | 15 | Tumor | 1058 | R | CrI, CrII, VIIB |
| 9 | F | 63 | 16 | Vascular | 864 | R | I, II, III, IV, V, VI, VIIIA, CrI |
| 10 | M | 36 | 14 | Tumor | 1379 | L | VIIIA, VIIB, CrI, CrII |
| 11 | M | 47 | 12 | Vascular | 91 | L | VIIIA, VIIB, CrI, CrII, V, VI |
Figure 1Depicts the layout of the covert attention task. Participants were asked to fixate while attending to landmarks (i.e., green circles) located 12° to the left and right of fixation. At the beginning of a trial one of the two landmarks would brighten, reflexively cuing the participant's attention to that location. Following an SOA of 50, 150, or 300 ms a target (i.e., a red circle) would appear either at the cued (i.e., valid) or the uncued (i.e., invalid) location. Participants were asked to respond via a button press when the target appeared on the screen.
Mean reaction time (RT) data for controls (.
| Controls ( | 421 (38) | 465 (43) | 433 (38) | 439 (42) | 447 (54) | 433 (52) | 449 (39) | 413 (32) | 453 (31) | 409 (46) | 443 (39) | 423 (39) | 420 (33) | 449 (40) |
| Patient 1 | 415 | 437 | 368 | 398 | 403 | 403 | 499 | 396 | 434 | 388 | 385 | 405 | 395 | 447 |
| Patient 2 | 626 | 608 | 606 | 609 | 478 | 591 | 604 | 615 | 647 | 609 | 606 | 588 | 586 | 679 |
| Patient 3 | 526 | 546 | 539 | 540 | 495 | 491 | 557 | 563 | 552 | 524 | 537 | 482 | 465 | 572 |
| Patient 4 | 399 | 462 | 404 | 378 | 421 | 454 | 440 | 409 | 409 | 408 | 404 | 445 | 450 | 427 |
| Patient 5 | 444 | 457 | 368 | 415 | 343 | 358 | 499 | 431 | 460 | 365 | 423 | 352 | 399 | 486 |
| Patient 6 | 352 | 353 | 401 | 355 | 380 | 350 | 385 | 338 | 334 | 341 | 354 | 354 | 332 | 371 |
| Patient 7 | 481 | 510 | 454 | 518 | 461 | 533 | 497 | 520 | 497 | 420 | 483 | 502 | 509 | 509 |
| Patient 8 | 419 | 434 | 401 | 401 | 415 | 366 | 439 | 429 | 460 | 400 | 420 | 367 | 364 | 440 |
| Patient 9 | 370 | 433 | 367 | 402 | 371 | 434 | 407 | 384 | 439 | 383 | 429 | 415 | 420 | 404 |
| Patient 10 | 469 | 502 | 480 | 512 | 474 | 533 | 567 | 476 | 513 | 422 | 497 | 473 | 526 | 518 |
| Patient 11 | 379 | 431 | 430 | 419 | 436 | 443 | 419 | 415 | 426 | 417 | 430 | 439 | 420 | 405 |
| Patient group mean ( | 444 (80) | 470 (68) | 438 (77) | 450 (81) | 425 (49) | 450 (80) | 483 (72) | 452 (83) | 470 (82) | 425 (76) | 452 (73) | 438 (71) | 442 (75) | 478 (89) |
Standard deviations are in brackets.
Figure 2(A) Depicts the group (patients vs. controls) × cue (valid vs. invalid) × SOA (50, 150, 300 ms) interaction. (B) Depicts the cuing effect (invalid RT—valid RT) as a function of group (patients vs. controls) and SOA (50, 150, 300). In both graphs the error bars represent the within-subject standard error (Loftus and Masson, 1994). Statistically significant differences are denoted by *p < 0.05, corrected.
Figure 3Depicts the results of the lesion overlay analysis for the cerebellar patients (. Lesioned areas in each patient were manually traced onto a series of 12-4 mm thick axial cerebellar slices based on the templates first developed by Tatu et al. (1996). Structural labels and anatomical boundaries were determined by comparing sections of the cerebellar template with horizontal MRI and histology sections from the MRI Atlas of the Human Cerebellum (Schmahmann, 2000). Slice 1 starts at the most inferior portion of the cerebellum and moves upward in 4 mm increments toward more superior portions of the cerebellum. Gray portions represent the area of the patient's lesions. Darker gray regions represent areas of significant overlap between patients. The regions of greatest overlap were in Crus I and Crus II of the lateral cerebellum.